Schedule 13G ownership disclosure

KalVista Pharmaceuticals Inc

Common Stock, par value $0.001 per share · CUSIP: 483497103

Event date: 2025-11-04

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Millennium Management LLC

    Shares: 2,531,010.00 · Class: 5.0%

  • Millennium Group Management LLC

    Shares: 2,531,010.00 · Class: 5.0%

  • Israel A. Englander

    Shares: 2,531,010.00 · Class: 5.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-109172
Form type
SCHEDULE 13G
Filer
KalVista Pharmaceuticals, Inc.
CIK
CIK 1348911
Filed
Nov 10, 2025
Reporting period
Nov 04, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub